All In Biotech

Drug Trial Radar · NCT00200460

A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients

A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Dosing Study Evaluating the Effects of Nebivolol on Blood Pressure in Patients With Mild to Moderate Hypertension

Last checked: Nov 20, 2026Latest source record: Sep 20, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 825 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

825

Actual

Start

Sep 2001

Primary completion

Not stated

Study completion Mar 2003

Sponsor

Lead sponsor
Mylan Bertek PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Sep 20, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effects of various doses of nebivolol in patients with mild to moderate hypertension.

Conditions

  • Hypertension

Interventions

  • NebivololDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The change of the average sitting diastolic blood pressure taken at trough drug plasma level at the end of treatment compared to baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mylan Pharmaceuticals Inc.

    Morgantown, West Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.